Pharmaceutical giant Pfizer announced on Friday that it will issue 40 million COVID-19 vaccine doses to poor countries at cost price, via global initiative COVAX.
We are proud to announce that Pfizer & BioNTech have signed an agreement with #COVAX for up to 40M doses of our #COVID19 vaccine. This is an important step in the fight against the virus – a fight that will only end when we have #OneWorldProtected. @who @gavi @cepivaccines
— Pfizer Inc. (@pfizer) January 22, 2021
The initiative is a collective of 64 higher-income economies made to ensure vaccine procurement and distribution to lower-income countries who, through COVAX, should receive doses by the first quarter of 2021.
This ground-breaking development remedies WHO director-general Dr Tedros Adhanom Ghebreyesus’ previous fears of a ‘moral catastrophe’ where richer countries vaccinated without too much difficulty as poorer countries crumbled.
#MaltaDaily